TriSalus Life Sciences, Inc.
TLSI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.
Other share classesTLSIW
13F holders, Q3 2024
Institutional positions in TriSalus Life Sciences, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +5 vs. Q2 2024
- Shares held
- 2.17M
- +416.4K (+23.7%) vs. Q2 2024
- Total value
- $10.0M
- +$974.1K (+10.8%) vs. Q2 2024
- New holders
- 11
- 3 more added
- Sold out
- 6
- 9 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $99.0M |
| Q1 2026 | 84 | $83.4M |
| Q4 2025 | 64 | $79.6M |
| Q3 2025 | 56 | $44.5M |
| Q2 2025 | 46 | $46.2M |
| Q1 2025 | 34 | $16.3M |
| Q4 2024 | 28 | $11.8M |
| Q3 2024 | 31 | $10.0M |
| Q2 2024 | 27 | $9.20M |
| Q1 2024 | 25 | $9.03M |
| Q4 2023 | 19 | $5.74M |
| Q3 2023 | 9 | $699.3K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding TriSalus Life Sciences, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 1 | $5 | 0.00% | −1,225−99.9% | Reduced |
| UBS Group AG | 22 | $101 | 0.00% | −1,966−98.9% | Reduced |
| JPMorgan Chase & Co | 25 | $115 | 0.00% | +5+25.0% | Added |
| Signaturefd, LLC | 100 | $461 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 148 | $682 | 0.00% | +48+48.0% | Added |
| Hoertkorn Richard Charles | 668 | $3.08K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,135 | $5.23K | 0.00% | −837−42.4% | Reduced |
| Tower Research Capital LLC (TRC) | 1,703 | $7.85K | 0.00% | −4,217−71.2% | Reduced |
| Wolverine Asset Management LLC | 4,748 | $21.9K | 0.00% | −38,732−89.1% | Reduced |
| Two Sigma Securities, LLC | 10,192 | $47.0K | 0.00% | +10,192 | New |
| State Street Corp | 11,100 | $51.2K | 0.00% | 00.0% | Unchanged |
| Magnetar Financial LLC | 14,232 | $65.6K | 0.00% | +14,232 | New |
| Walleye Capital LLC | 14,376 | $66.3K | 0.00% | +14,376 | New |
| Gilder Gagnon Howe & Co LLC | 14,440 | $66.6K | 0.00% | +14,440 | New |
| Bridgeway Capital Management, LLC | 15,000 | $69.2K | 0.00% | +15,000 | New |
| HRT Financial LP | 15,575 | $71.0K | 0.00% | −19,966−56.2% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 15,554 | $72.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 19,875 | $92.0K | 0.01% | +19,875 | New |
| Angelo Gordon & Co., L.P. | 20,854 | $96.1K | 0.03% | +20,854 | New |
| Vestcor Inc | 23,376 | $108.0K | 0.00% | +23,376 | New |
| Northern Trust Corp | 26,176 | $120.7K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 30,270 | $139.5K | 0.00% | +30,270 | New |
| Connecticut Wealth Management, LLC | 32,879 | $151.6K | 0.01% | 00.0% | Unchanged |
| Lido Advisors, LLC | 35,024 | $161.5K | 0.00% | −9,383−21.1% | Reduced |
| Exos Asset Management LLC | 38,604 | $178.0K | 17.27% | −129,006−77.0% | Reduced |
| MSD Partners, L.P. | 39,999 | $184.4K | 0.12% | +39,999 | New |
| Millennium Management LLC | 97,888 | $451.3K | 0.00% | −25,016−20.4% | Reduced |
| Geode Capital Management, LLC | 200,427 | $924.2K | 0.00% | +62,542+45.4% | Added |
| Vanguard Group Inc | 416,138 | $1.92M | 0.00% | 00.0% | Unchanged |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 426,921 | $1.97M | 0.07% | 00.0% | Unchanged |
| Wealthcare Advisory Partners LLC | 643,740 | $2.97M | 0.08% | +643,740 | New |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −214,545−100.0% | Sold out |
| Anson Capital, Inc. | 0 | $0 | 0.00% | −24,415−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −23,045−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −233−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Clear Street LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |